Pierre Leblond

3.6k total citations
123 papers, 1.9k citations indexed

About

Pierre Leblond is a scholar working on Genetics, Neurology and Molecular Biology. According to data from OpenAlex, Pierre Leblond has authored 123 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Genetics, 41 papers in Neurology and 30 papers in Molecular Biology. Recurrent topics in Pierre Leblond's work include Glioma Diagnosis and Treatment (50 papers), Neuroblastoma Research and Treatments (30 papers) and Childhood Cancer Survivors' Quality of Life (13 papers). Pierre Leblond is often cited by papers focused on Glioma Diagnosis and Treatment (50 papers), Neuroblastoma Research and Treatments (30 papers) and Childhood Cancer Survivors' Quality of Life (13 papers). Pierre Leblond collaborates with scholars based in France, Canada and Italy. Pierre Leblond's co-authors include Matthieu Vinchon, Nicolás André, Marc Baroncini, Isabelle Aerts, Claude Féo, Isabelle Delestret, Jacques Grill, Anne‐Isabelle Bertozzi, Birgit Geoerger and Marie‐Cécile Le Deley and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Internal Medicine.

In The Last Decade

Pierre Leblond

114 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Leblond France 25 664 563 462 382 373 123 1.9k
Nimish Mohile United States 22 1000 1.5× 441 0.8× 281 0.6× 489 1.3× 217 0.6× 89 1.8k
Guillaume Gauchotte France 28 372 0.6× 192 0.3× 437 0.9× 269 0.7× 395 1.1× 102 1.8k
Nicky D’Haene Belgium 24 393 0.6× 262 0.5× 610 1.3× 411 1.1× 195 0.5× 95 2.0k
Yoshihiro Yonekawa United States 30 201 0.3× 297 0.5× 813 1.8× 336 0.9× 234 0.6× 262 3.4k
Meinolf Suttorp Germany 32 1.2k 1.8× 217 0.4× 513 1.1× 230 0.6× 129 0.3× 184 4.0k
Mihaela Onciu United States 26 733 1.1× 290 0.5× 948 2.1× 211 0.6× 256 0.7× 54 3.8k
Andrea Rubbert‐Roth Germany 33 885 1.3× 306 0.5× 480 1.0× 256 0.7× 277 0.7× 123 5.1k
Adam J. Olszewski United States 28 781 1.2× 796 1.4× 539 1.2× 246 0.6× 233 0.6× 212 3.1k
Attilio Olivieri Italy 33 680 1.0× 131 0.2× 568 1.2× 260 0.7× 257 0.7× 156 3.6k
Paola Gaviani Italy 18 502 0.8× 166 0.3× 194 0.4× 334 0.9× 188 0.5× 69 1.2k

Countries citing papers authored by Pierre Leblond

Since Specialization
Citations

This map shows the geographic impact of Pierre Leblond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Leblond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Leblond more than expected).

Fields of papers citing papers by Pierre Leblond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Leblond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Leblond. The network helps show where Pierre Leblond may publish in the future.

Co-authorship network of co-authors of Pierre Leblond

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Leblond. A scholar is included among the top collaborators of Pierre Leblond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Leblond. Pierre Leblond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ritzmann, Timothy, Denise Obrecht, Martin Benesch, et al.. (2025). European standard clinical practice recommendations for newly diagnosed ependymoma of childhood and adolescence. EUR Research Repository (Erasmus University Rotterdam). 5. 100227–100227. 1 indexed citations
2.
Maureille, Aurélien, David Meyronet, Cécile Faure, et al.. (2025). Feasibility and efficacy of MEMMAT-like regimen in heavily pretreated adult patients with recurrent malignant embryonal brain tumors: A series of 6 cases. Neuro-Oncology Advances. 7(1). vdaf071–vdaf071.
3.
4.
5.
Beuriat, Pierre-Aurélien, et al.. (2024). Bone Morphogenic Proteins in Pediatric Diffuse Midline Gliomas: How to Make New Out of Old?. International Journal of Molecular Sciences. 25(6). 3361–3361. 1 indexed citations
6.
Poirée, Marilyne, Pierre Leblond, Valérie Laurence, et al.. (2024). A Review of GO-AJA’s Impact on Adolescents and Young Adults with Cancer in France: A Decade of Progress and Challenges. Journal of Adolescent and Young Adult Oncology. 14(2). 194–199. 1 indexed citations
7.
Vasiljevic, Alexandre, et al.. (2023). Bevacizumab as Single Agent in Children and Teenagers with Optic Pathway Glioma. Cancers. 15(4). 1036–1036. 6 indexed citations
8.
Geoerger, Birgit, Lynley V. Marshall, Karsten Nysom, et al.. (2023). Afatinib in paediatric patients with recurrent/refractory ErbB-dysregulated tumours: Results of a phase I/expansion trial. European Journal of Cancer. 188. 8–19. 3 indexed citations
9.
Bal-Mahieu, Christine, Ángel M. Carcaboso, Xuefen Le Bourhis, et al.. (2021). Evofosfamide Is Effective against Pediatric Aggressive Glioma Cell Lines in Hypoxic Conditions and Potentiates the Effect of Cytotoxic Chemotherapy and Ionizing Radiations. Cancers. 13(8). 1804–1804. 6 indexed citations
10.
Picard, Cécile, Cécile Faure‐Conter, Pierre Leblond, et al.. (2019). Exploring heterogeneity of adrenal cortical tumors in children: The French pediatric rare tumor group (Fracture) experience. Pediatric Blood & Cancer. 67(2). e28086–e28086. 13 indexed citations
11.
Mortuaire, G., et al.. (2016). Desmoid tumours of the head and neck in children: Review of management. European Annals of Otorhinolaryngology Head and Neck Diseases. 134(3). 155–160. 12 indexed citations
12.
Leblond, Pierre, Christine Bal-Mahieu, Marc Baroncini, et al.. (2013). Cilengitide targets pediatric glioma and neuroblastoma cells through cell detachment and anoikis induction. Anti-Cancer Drugs. 24(8). 818–825. 13 indexed citations
13.
André, Nicolás, Estelle Thébaud, Odile Minckes, et al.. (2012). Bevacizumab and irinotecan in children with recurrent or refractory brain tumors: Toxicity and efficacy trends. Pediatric Blood & Cancer. 59(1). 34–38. 43 indexed citations
14.
Macher, E, François Dubos, Nathalie Garnier, et al.. (2010). Predicting the risk of severe bacterial infection in children with chemotherapy‐induced febrile neutropenia. Pediatric Blood & Cancer. 55(4). 662–667. 43 indexed citations
15.
Rubie, Hervé, Birgit Geoerger, Didier Frappaz, et al.. (2010). Phase I study of topotecan in combination with temozolomide (TOTEM) in relapsed or refractory paediatric solid tumours. European Journal of Cancer. 46(15). 2763–2770. 15 indexed citations
16.
Geoerger, Birgit, Julia Chisholm, Marie‐Cécile Le Deley, et al.. (2010). Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium Study. European Journal of Cancer. 47(2). 230–238. 36 indexed citations
17.
André, Nicolás, Pierre Leblond, & Arnauld Verschuur. (2010). Spécificités pharmacologiques en oncologie pédiatrique. Bulletin du Cancer. 97(2). 191–198. 1 indexed citations
18.
Penel, Nicolas, Nicolás Isambert, Pierre Leblond, et al.. (2009). “Classical 3 + 3 design” versus “accelerated titration designs”: analysis of 270 phase 1 trials investigating anti-cancer agents. Investigational New Drugs. 27(6). 552–556. 20 indexed citations
19.
Bigot, Sylvain, et al.. (2005). Apport du dosage de la procalcitonine pour le diagnostic de pyélonéphrite aiguë de l'enfant. Archives de Pédiatrie. 12(7). 1075–1080. 24 indexed citations
20.
Leblond, Pierre, et al.. (2005). Impact de la conférence de consensus sur le traitement ambulatoire des bronchiolites du nourrisson. La Presse Médicale. 34(4). 277–281. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nimish Mohile Breakdown of academic impact, for papers by Guillaume Gauchotte Breakdown of academic impact, for papers by Nicky D’Haene Breakdown of academic impact, for papers by Yoshihiro Yonekawa Breakdown of academic impact, for papers by Meinolf Suttorp Breakdown of academic impact, for papers by Mihaela Onciu Breakdown of academic impact, for papers by Andrea Rubbert‐Roth Breakdown of academic impact, for papers by Adam J. Olszewski Breakdown of academic impact, for papers by Attilio Olivieri Breakdown of academic impact, for papers by Paola Gaviani
Rankless by CCL
2026